Serum amyloid A as an early predictor of severity in COVID-19

Serum amyloid A (SAA) is a well-established inflammation marker, in particular for viral infections. During the first SARS-CoV-1 epidemic in 2004 and again during the SARS-CoV-2 pandemic, SAA has proven to be the best inflammation marker to predict and monitor COVID-19 severity and disease progression. In this webinar, Dr. Pouw reintroduces SAA and summarizes its utility in COVID-19 disease management.

Nadine Pouw, Franciscus, Gasthuis & Vlietland

Dr. Nadine Pouw
Franciscus, Gasthuis & Vlietland